Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Drägerwerk AG & Co. KGaA (DRWKF)

67.28
0.00
(0.00%)
At close: April 30 at 4:00:00 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Stefan A. Drager B.A. Chairman of the Executive Board - Drägerwerk Verwaltungs AG 1.38M -- 1963
Mr. Gert-Hartwig Lescow CFO, Executive Board Member for IT & Vice Chairman of Executive Board - Drägerwerk Verwaltungs AG 1.04M -- 1967
Mr. Anton Schrofner Executive Board Member for Medical Division - Drägerwerk Verwaltungs AG 672.24k -- 1963
Mr. Rainer Klug Executive Board Member for Safety Division - Drägerwerk Verwaltungs AG 1.05M -- 1968
Dr. Reiner Piske Executive Board Member for Sales & Human Resources - Drägerwerk Verwaltungs AG 701.51k -- 1970
Ms. Stefanie Hirsch Executive Board Member for Sustainability & Quality - Drägerwerk Verwaltungs AG 26.19k -- 1975
Mr. Thomas Fischler Head of Treasury & Investor Relations -- -- --
Mr. Welf Böttcher Head of Corporate Communications -- -- --

Drägerwerk AG & Co. KGaA

Moislinger Allee 53-55
Lübeck, 23558
Germany
49 451 882 3202 https://www.draeger.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
15,444

Description

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. Its products include patient monitoring systems; anaesthesia machines; medical ventilators and lung monitoring; neonatal incubators and thermoregulation; phototherapy lights and bilirubinometers; surgical and examination lights; medical pendants and infrastructure design; medical gas pipeline system in hospitals; and hospital consumables and accessories, as well as hospital planning and design services. In addition, the company offers alcohol and drug testing; fixed gas detectors; hazmat suits; portable gas detection; head protection; rescue and escape; respiratory protection; safety-training systems; thermal imaging cameras; and workshop solution and breathing gas supply. Further, it provides various training and services. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh.

Corporate Governance

Drägerwerk AG & Co. KGaA’s ISS Governance QualityScore as of May 1, 2025 is 8. The pillar scores are Audit: 6; Board: 6; Shareholder Rights: 10; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 12, 2025 at 12:00 AM UTC

Ex-Dividend Date

July 29, 2025 at 5:30 AM UTC

Drägerwerk AG & Co. KGaA Earnings Date

Recent Events